Oncology billing is one of the most complicated revenue cycles in healthcare due to expensive chemotherapy infusion drugs, the complexity of drug administration codes, the prevalence of prior authorizations, and the investigation of costly biologics and immunotherapies by payers. One mistake in coding will cost thousands per claim.
Acuity Health Solutions is an oncology billing services company whose precision oncology revenue cycle management optimizes reimbursements and complies with them. Being a reputable oncology billing firm in the USA, we assist medical oncology, hematology, radiation oncology, and infusion centers to obtain 98% of clean claim rates.
Oncology generates high‑dollar claims but faces high denial risks:
Industry Stats: Oncology denial rates are 18-25% as compared to 10% industry standard.
CPT 96413: Chemo administration, 1 hour
J9190: Cyclophosphamide injection
J9250: Methotrexate sodium
Q0083-Q0085: Chemo drug reimbursement
End‑to‑end oncology RCM:
96413-96417 Chemo administration
J9000-J9999 Chemotherapy drugs
77301 IMRT planning
G6001 SRS delivery
Oncology prior authorizations create significant revenue bottlenecks for oncology billing services:
92% PA approval rate vs. industry 65%, reducing treatment delays by 7-10 days. Our oncology revenue cycle management eliminates the #1 cause of oncology claim denials while ensuring patients receive therapies faster.
Acuity Health Solutions is a solution that combines with oncology-optimized systems that provide a fully functioning oncology revenue cycle management.
J-code precision tracking eliminates revenue leakage:
High‑Value Drug Examples:
J9265: Paclitaxel 30mg ($250/dose)
J9190: Cyclophosphamide ($15/dose)
J9271: Pembrolizumab ($12K/dose)
C9047: CAR‑T therapy ($475K/treatment)
Oncology payers demand strict adherence:
HIPAA oncology data security
Real‑Time Oncology Dashboards:
Findings
99% J -code rate, 98% clean claims, 15% improvement of oncology practices’ drug reimbursement rates nationwide.
Acuity Health Solutions is a solution that combines with oncology-optimized systems that provide a fully functioning oncology Revenue Cycle Management.
J-code precision tracking eliminates revenue leakage:
Automated verification of NDC (11-digit matching)
Buy-and-bill reconciliation (used vs. purchased drug).
340B split billing (covered vs. non‑covered services)
JW automation of the modifier (waste reporting).
High‑Value Drug Examples:
J9265: Paclitaxel 30mg ($250/dose)
J9190: Cyclophosphamide ($15/dose)
J9271: Pembrolizumab ($12K/dose)
C9047: CAR‑T therapy ($475K/treatment)
Oncology payers demand strict adherence:
HIPAA oncology data security
Real‑Time Oncology Dashboards:
99% J -code rate, 98% clean claims, 15% improvement of oncology practices’ drug reimbursement rates nationwide.
Certified Oncology Billing Specialists:
Results:
25% denial reduction
15% revenue increase
A/R: 42 → 28 days
340B compliance
Get Started: Free oncology billing analysis- investigate your top 10 J-codes and denial rates today.